Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adc Therapeutics Sa
(NY:
ADCT
)
3.220
+0.150 (+4.89%)
Streaming Delayed Price
Updated: 2:23 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Adc Therapeutics Sa
< Previous
1
2
3
4
5
6
7
8
Next >
ADC Therapeutics Announces Medical Leadership Transition
September 03, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Announces $325M Financing Agreement With HealthCare Royalty
August 26, 2021
ADC Therapeutics SA (NYSE: ADCT) has entered into a royalty purchase agreement with HealthCare Royalty Partners for up to $325 million. ADC Therapeutics...
Via
Benzinga
ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325 Million
August 26, 2021
From
ADC Therapeutics SA
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2021
August 09, 2021
Upgrades DA Davidson upgraded the previous rating for AAON Inc (NASDAQ:
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
ADC Therapeutics SA (ADCT) Q2 2021 Earnings Call Transcript
August 03, 2021
ADCT earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
ADC Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates
August 03, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics to Host Second Quarter 2021 Financial Results Conference Call on August 3, 2021
July 28, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Announces Encouraging Interim Results from Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) Presented at the 16th Annual International Conference on Malignant Lymphoma
June 22, 2021
From
ADC Therapeutics SA
Via
Business Wire
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
ADC Therapeutics Presents Updated ZYNLONTA™ (loncastuximab tesirine-lpyl) Clinical Data at 16th Annual International Conference on Malignant Lymphoma
June 18, 2021
From
ADC Therapeutics SA
Via
Business Wire
Expert Ratings for ADC Therapeutics
June 15, 2021
Within the last quarter, ADC Therapeutics (NYSE:ADCT) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 0 2 1...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
June 15, 2021
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...
Via
Benzinga
ADC Therapeutics Shareholders Approve All Resolutions at the Annual General Meeting
June 11, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Announces Presentations at the 16th Annual International Conference on Malignant Lymphoma
June 09, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Presents Updated Clinical Data at 2021 ASCO Annual Meeting
June 04, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics to Present at Jefferies Virtual Healthcare Conference
May 27, 2021
From
ADC Therapeutics SA
Via
Business Wire
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Exposures
Product Safety
ADC Therapeutics Announces Online Publication of Camidanlumab Tesirine Phase 1 Results in The Lancet Haematology
May 26, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Announces Presentations at the 2021 ASCO Annual Meeting
May 19, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Announces Receipt of $50 Million Second Tranche of Convertible Credit Facility with Deerfield
May 17, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Announces Online Publication of LOTIS-2 Results in The Lancet Oncology
May 12, 2021
From
ADC Therapeutics SA
Via
Business Wire
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
May 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
ADC Therapeutics SA (ADCT) Q1 2021 Earnings Call Transcript
May 06, 2021
ADCT earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
ADC Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Updates
May 06, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics’ ZYNLONTA™ (loncastuximab tesirine-lpyl) Added to National Comprehensive Cancer Network® Clinical Practice Guidelines in Oncology for B-cell Lymphomas
May 05, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics to Participate in May Investor Conferences
May 04, 2021
From
ADC Therapeutics SA
Via
Business Wire
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.